Disclosures: Dr. Merrill has served as a consultant and clinical trialist for Genentech/Roche, Bristol-Myers Squibb Co., MedImmune Inc., and Human Genome Sciences; she has been a consultant for Amgen Inc., UCB Pharma Inc., and Serono Inc.; and she has received grants from Aspreva/Vifor and Wyeth/Pfizer for investigator-initiated studies.
In lupus, 'targeted therapies can only work if you know what you're targeting, in whom, and why.'
Source DR. MERRILL